ELLEN LENTZ: Open Payments
NPI 1306949193 · WASILLA, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 31 payments from 9 companies in 2025. Trend: 2023 $1,096 · 2024 $1,231 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $189 |
| Aimmune Therapeutics, Inc. | 4 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $84 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Novo Nordisk Inc | 2 | $37 |
| Exact Sciences Corporation | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Digestive Care, Inc. | 1 | $18 |
Products named: VRAYLAR, ZENPEP, AIRSUPRA, Wegovy, Cologuard Collection Kit, VOWST, GEMTESA, UBRELVY.
Industry payments across AK — which companies pay providers there.
